Nova Patents
IL233583B

A pharmaceutical composition comprising stable, amorphous hybrid nanopraticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

163 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims21

Priority claims
DocumentOfficeKindDate
1250015SwedenA
1250015SwedenA
201261586187United States of AmericaP
201261586187United States of AmericaP
1251160SwedenA
1251160SwedenA
201261713120United States of AmericaP
201261713120United States of AmericaP
2013050016SwedenW
2013050016SwedenW
12500153–––
12511606–––
61586187–––
61713120–––
PCTSE2013050016–––
SE20120050015–––
SE20120051160–––
US201261586187P–––
US201261713120P–––
WO2013FR50016–––
WO2013SE50016–––

Members163

Family members, oldest first
DocumentOfficeKind
CA2860932A1CanadaA1
CA2860973A1CanadaA1
WO2013105894A1World Intellectual Property Organization (WIPO)A1
WO2013105895A1World Intellectual Property Organization (WIPO)A1
AU2013208323A1AustraliaA1
AU2013208324A1AustraliaA1
IL233582A0IsraelA0
IL233582D0IsraelD0
IL233583A0IsraelA0
IL233583D0IsraelD0
CN104159574AChinaA
CN104159577AChinaA
EP2802314A1European Patent Office (EPO)A1
EP2802316A1European Patent Office (EPO)A1
US2014356443A1United States of AmericaA1
US2014378454A1United States of AmericaA1
JP2015503612AJapanA
JP2015503613AJapanA
MX2014008457AMexicoA
IN6529DEN2014AIndiaA
EP2802314A4European Patent Office (EPO)A4
EP2802316A4European Patent Office (EPO)A4
US2016250153A1United States of AmericaA1
US9456992B2United States of AmericaB2
US2016361313A1United States of AmericaA1
CN104159577BChinaB
MX347456BMexicoB
US2017143683A1United States of AmericaA1
US2017143715A1United States of AmericaA1
EP3181122A1European Patent Office (EPO)A1
EP3181127A1European Patent Office (EPO)A1
EP3181128A1European Patent Office (EPO)A1
AU2013208323B2AustraliaB2
CN107115317AChinaA
CN107115318AChinaA
AU2013208324B2AustraliaB2
US9827230B2United States of AmericaB2
JP6238310B2JapanB2
JP6238311B2JapanB2
US9833442B2United States of AmericaB2
US9833443B2United States of AmericaB2
JP2017222693AJapanA
JP2017222694AJapanA
JP2017222695AJapanA
JP2018008973AJapanA
JP2018012713AJapanA
JP2018012714AJapanA
US2018042906A1United States of AmericaA1
AU2018200928A1AustraliaA1
AU2018200931A1AustraliaA1
AU2018200933A1AustraliaA1
JP2018035147AJapanA
JP6351809B2JapanB2
JP6351810B2JapanB2
JP6351811B2JapanB2
JP2018172393AJapanA
US10143683B2United States of AmericaB2
JP6463416B2JapanB2
JP6463417B2JapanB2
JP6463418B2JapanB2
JP6463419B2JapanB2
US2019060294A1United States of AmericaA1
US2019076413A1United States of AmericaA1
JP2019070000AJapanA
JP2019070000AJapanA
US10314829B2United States of AmericaB2
US10314830B2United States of AmericaB2
AU2018200928B2AustraliaB2
AU2018200931B2AustraliaB2
US2019255029A1United States of AmericaA1
US2019275018A1United States of AmericaA1
US2019275019A1United States of AmericaA1
US2019282553A1United States of AmericaA1
AU2019275513A1AustraliaA1
AU2018200933B2AustraliaB2
JP6628834B2JapanB2
MX371209BMexicoB
MX371297BMexicoB
MX371349BMexicoB
US10555937B2United States of AmericaB2
US10561643B2United States of AmericaB2
US10561644B2United States of AmericaB2
US10561645B2United States of AmericaB2
JP2020055838AJapanA
MX2020000984AMexicoA
US2020253941A1United States of AmericaA1
IL276036D0IsraelD0
US10772877B2United States of AmericaB2
IL233583AIsraelA
IL233583BThis recordIsraelB
EP2802314B1European Patent Office (EPO)B1
EP3766486A1European Patent Office (EPO)A1
DK2802314T3DenmarkT3
JP6828123B2JapanB2
CA2860932CCanadaC
HRP20210237T1CroatiaT1
US2021093616A1United States of AmericaA1
JP2021073228AJapanA
JP2021073228AJapanA
PL2802314T3PolandT3
Showing 100 of 163